Internal Medicine, Hematology & Oncology · Sarasota, FL
NPI
1730178658
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3830 Bee Ridge Rd, Suite 100
Sarasota, FL, 34233
Phone (941) 923-1872
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.5M
235,792 services
Medicare patients, 2024
625
Average age 77
Drug cost, 2024
$7.8M
3,031 prescriptions
Company payments, 2025
$4,953
From 53 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven W Mamus was code J1439 (injection, ferric carboxymaltose, 1 mg), 55,500 times for 33 patients. In total Steven W Mamus billed 235,792 services in 124 codes, and Medicare paid $3.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 55,500 | 33 | $0.88 | $49K |
| J0897 Injection, denosumab, 1 mg | Office | 15,420 | 54 | $18.82 | $290K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 14,600 | 14 | $30.13 | $440K |
| J1201 Injection, cetirizine hydrochloride, 0.5 mg | Office | 5,040 | 70 | $11.71 | $59K |
| Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg | Office | 5,030 | 15 | $46.37 | $233K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 5,000 | 21 | $6.54 | $33K |
| 85025 Blood Count | Office | 3,032 | 612 | $7.60 | $23K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,943 | 95 | $0.09 | $265 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,750 | 30 | $0.71 | $1,251 |
| 99214 Office E&M - Established | Office | 1,729 | 414 | $92.58 | $160K |
| 96375 Injection Administration | Office | 1,014 | 105 | $11.44 | $12K |
| 99213 Office E&M - Established | Office | 881 | 353 | $63.88 | $56K |
| 96372 Injection Administration | Office | 406 | 89 | $10.68 | $4,338 |
| 96413 Chemotherapy Administration | Office | 374 | 68 | $95.28 | $36K |
| 96401 Chemotherapy Administration | Office | 319 | 26 | $52.97 | $17K |
By year: 2022 $4.0M for 291,584 services; 2023 $4.1M for 238,400 services; 2024 $3.5M for 235,792 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 3,032 | 612 | $7.60 | $23K |
| 85610 Clinical Chemistry | 306 | 30 | $4.20 | $1,285 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven W Mamus prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 134 prescriptions and refills. In total Steven W Mamus wrote 3,031 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 134 | 138 | 46 | $3,188 |
| Fentanyl Generic | 130 | 133 | 15 | $27K |
| Oxycodone Hcl Generic | 122 | 122 | 22 | $4,084 |
| Alprazolam Generic | 109 | 170 | 26 | $900 |
| Warfarin Sodium Generic | 102 | 261 | 29 | $1,503 |
| Hydroxyurea Generic | 96 | 253 | 28 | $3,030 |
| Letrozole Generic | 83 | 224 | 23 | $1,853 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 83 | 83 | Under 11 | $604K |
| Eliquis Apixaban | 79 | 139 | 19 | $80K |
| Ondansetron Odt Ondansetron | 73 | 81 | 48 | $2,766 |
| Anastrozole Generic | 73 | 197 | 23 | $1,162 |
| Prednisone Generic | 70 | 100 | 35 | $360 |
| Cephalexin Generic | 59 | 59 | 42 | $805 |
| Venclexta Venetoclax | 53 | 53 | Under 11 | $661K |
| Furosemide Generic | 50 | 111 | 16 | $109 |
Brand drugs: - claims; generic drugs: 2,202 claims; opioid claims: 523.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven W Mamus $4,953 ($4,953 in general payments such as food, travel and fees) from 53 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $528.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 22 | $528 |
| Pfizer Inc. PFE | 15 | $372 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $324 |
| Celgene Corporation BMY | 8 | $243 |
| BeOne Medicines USA, Inc. ONC | 10 | $226 |
| Merck Sharp & Dohme LLC MRK | 7 | $194 |
| GlaxoSmithKline, LLC. GSK | 7 | $188 |
| Janssen Biotech, Inc. JNJ | 12 | $185 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $168 |
| Abbvie Inc. ABBV | 6 | $142 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.